SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-029257
Filing Date
2016-11-14
Accepted
2016-11-14 16:30:49
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20160930.htm 10-Q 1793117
2 EX-31.1 aimt-ex311_9.htm EX-31.1 18070
3 EX-31.2 aimt-ex312_7.htm EX-31.2 18054
4 EX-32.1 aimt-ex321_10.htm EX-32.1 16931
  Complete submission text file 0001564590-16-029257.txt   5536021

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aimt-20160930.xml EX-101.INS 1240653
6 XBRL TAXONOMY EXTENSION SCHEMA aimt-20160930.xsd EX-101.SCH 29015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20160930_cal.xml EX-101.CAL 31402
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20160930_def.xml EX-101.DEF 110458
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20160930_lab.xml EX-101.LAB 272027
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20160930_pre.xml EX-101.PRE 198840
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 161995168
SIC: 2834 Pharmaceutical Preparations